Evidence map›Paper›PMID 36499214›Full record

ReviewInternational journal of molecular sciences2022

Mitochondrial Control in Inflammatory Gastrointestinal Diseases.

Guo-Yan Sui, Feng Wang, Jin Lee, Yoon Seok Roh

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Guo-Yan SuiCollege of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju 28160, Republic of Korea.
Feng WangCollege of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju 28160, Republic of Korea.
Jin LeeDepartment of Pathology, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Yoon Seok RohCollege of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju 28160, Republic of Korea.

Funding

Korean Food and Drug Administration 20182MFDS425National Research Foundation of Korea 2017R1A5A2015541 AND 2019R1A2C1090178Regional Innovation Strategy grant from the Ministry of Education, South Korea 2021RIS-001
6 · The paper itself

Abstract

Mitochondria play a central role in the pathophysiology of inflammatory bowel disease (IBD) and colorectal cancer (CRC). The maintenance of mitochondrial function is necessary for a stable immune system. Mitochondrial dysfunction in the gastrointestinal system leads to the excessive activation of multiple inflammatory signaling pathways, leading to IBD and increased severity of CRC. In this review, we focus on the mitochondria and inflammatory signaling pathways and its related gastrointestinal diseases.

Indexed as

Colorectal NeoplasmsInflammatory Bowel DiseasesHumansMitochondriaSignal Transductionbiogenesiscolorectal cancerinflammatory bowel diseasemitochondriamitophagy

Identifiers

PMID36499214
PMCPMC9736936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.